X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 6,759 | N/A |
| Receivables | 1,541 | N/A |
| TOTAL | $8,387 | $N/A |
| Non-Current Assets | ||
| PPE Net | 760 | N/A |
| Other Non-Current Assets | 363 | 0 |
| TOTAL | $1,123 | $N/A |
| Total Assets | $9,510 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 673 | 0 |
| Accrued Expenses | 1,541 | N/A |
| Other current liabilities | 1,793 | N/A |
| TOTAL | $6,677 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 4,704 | N/A |
| Deferred Revenues | 430 | N/A |
| Other Non-Current Liabilities | 70 | 0 |
| TOTAL | $7,207 | $N/A |
| Total Liabilities | $13,884 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 1 | N/A |
| Retained earnings | -35,413 | N/A |
| Other shareholders' equity | 30,666 | 0 |
| TOTAL | $-4,374 | $N/A |
| Total Liabilities And Equity | $9,510 | $0 |